Display Settings:

Format

Send to:

Choose Destination
    Vaccine. 1996 Jul;14(10):959-62.

    Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection.

    Source

    Department of Animal Health and Biomedical Sciences, University of Wisconsin, Madison 53706, USA.

    Abstract

    BALB/c mice were immunized with the recombinant Brucella abortus L7/L12 ribosomal protein fused to maltose binding protein (MBP). Vaccinated animals mounted a specific immune response to the recombinant fusion protein as demonstrated by immunoblot analyses. Additionally, B. abortus L7/L12 ribosomal protein conferred a significant degree of protection when compared to mice vaccinated with adjuvant alone, adjuvant plus MBP or B. abortus. These results indicate that a recombinant B. abortus protein, previously identified as T-cell-reactive, engendered protective immunity to mice against brucellosis.

    PMID:
    8873388
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk